- Home
- IDA vs HALO Comparison
IDA vs HALO Comparison
Compare IDA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IDA | HALO |
|---|---|---|
| Founded | 1915 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 8.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IDA | HALO |
|---|---|---|
| Price | $133.88 | $71.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $135.13 | $76.42 |
| AVG Volume (30 Days) | 440.4K | ★ 1.7M |
| Earning Date | 02-19-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | 7.17 | ★ 56.68 |
| EPS | ★ 5.84 | 4.74 |
| Revenue | ★ $1,805,885,000.00 | $1,242,852,000.00 |
| Revenue This Year | $6.64 | $34.54 |
| Revenue Next Year | $8.06 | $26.28 |
| P/E Ratio | $22.78 | ★ $14.87 |
| Revenue Growth | N/A | ★ 31.19 |
| 52 Week Low | $107.27 | $47.50 |
| 52 Week High | $138.03 | $79.50 |
Technical Indicators
Market Signals| Indicator | IDA | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 64.98 | 56.01 |
| Support Level | $130.83 | $69.53 |
| Resistance Level | $134.88 | $74.08 |
| Average True Range (ATR) | 2.23 | 2.13 |
| MACD | 0.79 | -0.10 |
| Stochastic Oscillator | 91.76 | 54.90 |
Price Performance
Historical ComparisonAbout IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.